z-logo
Premium
Women With Pregnancy and Lactation–Associated Osteoporosis (PLO) Have Low Bone Remodeling Rates at the Tissue Level
Author(s) -
Cohen Adi,
KamandaKosseh Mafo,
Dempster David W,
Zhou Hua,
Müller Ralph,
Goff Elliott,
Colon Ivelisse,
Bucovsky Mariana,
Stubby Julie,
Nickolas Thomas L,
Stein Emily M,
Recker Robert R,
Lappe Joan M,
Shane Elizabeth
Publication year - 2019
Publication title -
journal of bone and mineral research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.882
H-Index - 241
eISSN - 1523-4681
pISSN - 0884-0431
DOI - 10.1002/jbmr.3750
Subject(s) - medicine , pregnancy , osteoporosis , lactation , bone remodeling , bone mineral , apposition , physiology , obstetrics , genetics , biology
Pregnancy and lactation–associated osteoporosis (PLO) is a rare, severe, early form of osteoporosis in which young women present with fractures, usually multiple vertebral fractures, during late pregnancy or lactation. In studies of idiopathic osteoporosis (IOP) in premenopausal women, we enrolled 78 women with low‐trauma fractures and 40 healthy controls, all with normal menses and no secondary cause of bone loss. In 15 of the affected women, the PLO subgroup, fractures had occurred during late pregnancy or lactation. We hypothesized that clinical, bone structural, and metabolic characteristics would differ between women with PLO and those with (non‐PLO) IOP and controls. All were evaluated > 12 months postpartum, when structural and remodeling characteristics would be expected to reflect baseline premenopausal status rather than transient postpartum changes. As previously reported, affected subjects (PLO and IOP) had BMD and microarchitectural deficiencies compared to controls. Women with PLO did not differ from those with IOP in terms of age, BMI, body fat, menarcheal age, parity, or age at first pregnancy. However, women with PLO had a more severe clinical presentation than those with IOP: more fractures (5.5 ± 3.3 versus 2.6 ± 2.1; p  = 0.005); more vertebral fractures (80% versus 17%; p  < 0.001); and higher prevalence of multiple fractures. BMD deficits were more profound and cortical width tended to be lower in PLO. PLO subjects also had significantly lower tissue‐level mineral apposition rate and bone formation rates (0.005 ± 0.005 versus 0.011 ± 0.010 mm 2 /mm/year; p  = 0.006), as well as lower serum P1NP (33 ± 12 versus 44 ± 18 µg/L; p  = 0.02) and CTX (257 ± 102 versus 355 ± 193 pg/mL; p  = 0.01) than IOP. The finding that women with PLO have a low bone remodeling state assessed more than a year postpartum increases our understanding of the pathogenic mechanism of PLO. We conclude that women with PLO may have underlying osteoblast functional deficits which could affect their therapeutic response to osteoanabolic medications. © 2019 American Society for Bone and Mineral Research.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here